XML 23 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
Correction of Immaterial Errors To Prior Period Financial Statements
9 Months Ended
Mar. 31, 2017
Accounting Changes and Error Corrections [Abstract]  
Correction of Immaterial Errors To Prior Period Financial Statements
CORRECTION OF IMMATERIAL ERRORS TO PRIOR PERIOD FINANCIAL STATEMENTS

Accounting Review

During the fourth quarter of fiscal 2016, the Company identified the practice of granting additional concessions to certain distributors in the United States and commenced an internal accounting review in order to (i) determine whether the revenue associated with those concessions was accounted for in the correct period and (ii) evaluate the Company’s internal control over financial reporting. The Audit Committee of the Company’s Board of Directors separately conducted an independent review of these matters and retained independent counsel to assist in their review. On November 16, 2016, the Company announced that the independent review of the Audit Committee was completed and that the review found no evidence of intentional wrongdoing in connection with the preparation of the Company’s financial statements. The aforementioned reviews identified material weaknesses in our internal control over financial reporting. Refer to “Part I, Item 4. Controls and Procedures” of the Form 10-Q for a description of these material weaknesses and management’s plan and implementation of remediation efforts to address these material weaknesses.

Although the initial focus of the Company’s internal accounting review discussed above pertained to the evaluation of the timing of the recognition of the revenue associated with the practice of granting additional concessions to certain distributors, the Company subsequently expanded its internal accounting review and performed an analysis of previously-issued financial statements in order to identify and assess other potential errors. Based upon this review, the Company identified certain immaterial errors relating to its previously-issued financial statements which resulted in revisions to our previously-issued financial statements. Accordingly, prior period amounts presented in the consolidated financial statements and the related notes have been revised (referred to as the “Revision”). All costs incurred in connection with the internal accounting review, the Audit Committee’s independent review and related matters are included in “Accounting review costs,” in the Company’s Consolidated Statements of Income.

Based on an analysis of Accounting Standards Codification (“ASC”) 250 - “Accounting Changes and Error Corrections” (“ASC 250”), Staff Accounting Bulletin 99 - “Materiality” (“SAB 99”) and Staff Accounting Bulletin 108 - Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements (“SAB 108”), the Company determined that these errors were immaterial to the previously-issued financial statements; however, a cumulative correction of these errors would have had a material impact on the financial results for the three and twelve months ended June 30, 2016. Accordingly, we have revised our presentation of certain amounts in the consolidated financial statements for the three and nine months ended March 31, 2016 to reflect such corrections as if they had been recorded in the appropriate fiscal period.

We refer the reader to the Company’s Form 10-K for the fiscal year ended June 30, 2016 for a detailed explanation of the immaterial errors.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
 
Three Months Ended March 31, 2016
 
As Reported
 
Adjustment
 
As Revised
Net sales
$
749,862

 
$
(13,199
)
 
$
736,663

Cost of sales
576,653

 
102

 
576,755

    Gross profit
173,209

 
(13,301
)
 
159,908

Selling, general and administrative expenses
93,915

 
(15,025
)
 
78,890

Amortization of acquired intangibles
4,586

 
(33
)
 
4,553

Acquisition related expenses, restructuring and integration charges
  and other
5,701

 
(384
)
 
5,317

    Operating income
69,007

 
2,141

 
71,148

Interest and other financing expense, net
6,920

 

 
6,920

Other (income)/expense, net
378

 

 
378

Gain on fire insurance recovery
(9,013
)
 
 
 
(9,013
)
Income before income taxes and equity in earnings of equity-
  method investees
70,722

 
2,141

 
72,863

Provision for income taxes
21,576

 
2,338

 
23,914

Equity in net income of equity-method investees
161

 

 
161

Net income
$
48,985

 
$
(197
)
 
$
48,788

 
 
 
 
 
 
Net income per common share:
 
 
 
 
 
    Basic
$
0.47

 
$

 
$
0.47

    Diluted
$
0.47

 
$

 
$
0.47

 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
    Basic
103,265

 
103,265

 
103,265

    Diluted
104,087

 
104,087

 
104,087


* Net income per common share may not add in certain periods due to rounding

















CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (CONTINUED)
 
Nine Months Ended March 31, 2016
 
As Reported
 
Adjustment
 
As Revised
Net sales
$
2,189,639

 
$
(41,812
)
 
$
2,147,827

Cost of sales
1,686,820

 
(3,043
)
 
1,683,777

    Gross profit
502,819

 
(38,769
)
 
464,050

Selling, general and administrative expenses
262,776

 
(39,355
)
 
223,421

Amortization/impairment of acquired intangibles
13,994

 
(98
)
 
13,896

Acquisition related expenses, restructuring and integration charges
  and other
11,852

 
(617
)
 
11,235

    Operating income
214,197

 
1,301

 
215,498

Interest and other financing expense, net
19,760

 
(73
)
 
19,687

Other (income)/expense, net
8,771

 
73

 
8,844

Gain on fire insurance recovery
(9,013
)
 

 
(9,013
)
Income before income taxes and equity in earnings of equity-
  method investees
194,679

 
1,301

 
195,980

Provision for income taxes
57,337

 
2,509

 
59,846

Equity in net income of equity-method investees
108

 

 
108

Net income
137,234

 
(1,208
)
 
136,026

 
 
 
 
 
 
Net income per common share:
 
 
 
 
 
    Basic
$
1.33

 
$
(0.01
)
 
$
1.32

    Diluted
$
1.32

 
$
(0.01
)
 
$
1.31

 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
    Basic
103,030

 
103,030

 
103,030

    Diluted
104,168

 
104,168

 
104,168


* Net income per common share may not add in certain periods due to rounding
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
 
 
Three Months Ended March 31, 2016
 
Nine Months Ended March 31, 2016
 
 
As Reported
 
Adjustment
 
As Revised
 
As Reported
 
Adjustment
 
As Revised
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 
$
48,985

 
$
(197
)
 
$
48,788

 
$
137,234

 
$
(1,208
)
 
$
136,026

 
 
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
 
$
(20,296
)
 
$
193

 
(20,103
)
 
$
(86,380
)
 
690

 
(85,690
)
Change in deferred gains (losses) on cash flow hedging instruments
 
(1,209
)
 

 
(1,209
)
 
(164
)
 

 
(164
)
Change in unrealized gain (loss) on available for sale investment
 
20

 

 
20

 
(112
)
 

 
(112
)
Total other comprehensive income (loss)
 
$
(21,485
)
 
$
193

 
$
(21,292
)
 
$
(86,656
)
 
$
690

 
$
(85,966
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Total comprehensive income
 
$
27,500

 
$
(4
)
 
$
27,496

 
$
50,578

 
$
(518
)
 
$
50,060

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
 
Nine Months Ended March 31, 2016
 
As Reported
 
Adjustment
 
As Revised
CASH FLOWS FROM OPERATING ACTIVITIES
 
 
 
 
 
Net income
$
137,234

 
$
(1,208
)
 
$
136,026

Adjustments to reconcile net income to net cash provided by (used in) operating
  activities:
 
 
 
 
 
  Depreciation and amortization
47,494

 
605

 
48,099

  Deferred income taxes
(9,377
)
 
(155
)
 
(9,532
)
  Equity in net income of equity-method investees
108

 

 
108

  Stock-based compensation
10,005

 

 
10,005

  Contingent consideration expense
1,511

 

 
1,511

  Gain on fire insurance recovery and other, net
(8,401
)
 

 
(8,401
)
  Other non-cash items, including unrealized currency (gains)/loss, net
7,403

 

 
7,403

Increase (decrease) in cash attributable to changes in operating assets and
  liabilities, net of amounts applicable to acquisitions:
 
 
 
 
 
  Accounts receivable
(29,201
)
 
(1,260
)
 
(30,461
)
  Inventories
(11,397
)
 
621

 
(10,776
)
  Other current assets
(650
)
 
22,691

 
22,041

  Other assets and liabilities
1,111

 

 
1,111

  Accounts payable and accrued expenses
(13,986
)
 
(21,294
)
 
(35,280
)
     Net cash provided by operating activities
$
131,854

 
$

 
$
131,854



There were no adjustments to cash balances and to cash flows from investing and financing activities for the nine months ended March 31, 2016 as a result of the Revision.
SEGMENT NET SALES AND OPERATING INCOME (UNAUDITED)
 
Three months ended March 31, 2016
 
As Reported (1)
 
Adjustment
 
As Revised
Net Sales: 
 
 
 
 
 
United States
$
332,904

 
$
(7,520
)
 
$
325,384

United Kingdom
208,391

 
(2,231
)
 
$
206,160

Hain Pure Protein
113,643

 
(1,430
)
 
$
112,213

Rest of World
94,924

 
(2,018
)
 
$
92,906

 
$
749,862

 
$
(13,199
)
 
$
736,663

 
 
 
 
 
 
Operating Income:
 
 
 
 
 
United States
$
52,103

 
$
4,278

 
$
56,381

United Kingdom
16,217

 
(391
)
 
$
15,826

Hain Pure Protein
4,613

 
(2,186
)
 
$
2,427

Rest of World
8,641

 
(509
)
 
$
8,132

 
$
81,574

 
$
1,192

 
$
82,766

Corporate and Other
(12,567
)
 
949

 
(11,618
)
 
$
69,007

 
$
2,141

 
$
71,148


(1) The information previously reported for the three months ended March 31, 2016 has been adjusted to reflect the Company’s
new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment
Information, for additional details surrounding the formation of Cultivate.

 
Nine months ended March 31, 2016
 
As Reported (1)
 
Adjustment
 
As Revised
Net Sales: 
 
 
 
 
 
United States
$
970,368

 
$
(27,668
)
 
$
942,700

United Kingdom
567,971

 
(9,702
)
 
$
558,269

Hain Pure Protein
379,337

 
122

 
$
379,459

Rest of World
271,963

 
(4,564
)
 
$
267,399

 
$
2,189,639

 
$
(41,812
)
 
$
2,147,827

 
 
 
 
 
 
Operating Income:
 
 
 
 
 
United States
$
144,305

 
$
4,523

 
$
148,828

United Kingdom
45,189

 
(1,096
)
 
$
44,093

Hain Pure Protein
33,009

 
(1,931
)
 
$
31,078

Rest of World
17,910

 
(264
)
 
$
17,646

 
$
240,413

 
$
1,232

 
$
241,645

Corporate and Other
(26,216
)
 
69

 
(26,147
)
 
$
214,197

 
$
1,301

 
$
215,498


(1) The information previously reported for the nine months ended March 31, 2016 has been adjusted to reflect the Company’s
new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment
Information, for additional details surrounding the formation of Cultivate.